HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukemic dermal infiltrate at the exit site of a central venous catheter.

Abstract
This report describes the case of a minimally differentiated acute myeloid leukemia (FAB M0) diagnosed in a 55-year-old woman. During a second chemotherapy-induced complete remission, a subcutaneous nodule appeared at the scar of a recently removed Hickman catheter, which when biopsied revealed leukemic infiltration of the dermis and hypodermis. The patient had a bone marrow relapse three weeks later. The authors review similar recent reports and emphasize the importance of recognizing this particular type of cutaneous leukemic relapse.
AuthorsR Martino, A Sureda, D Sitjas, J Nomdedéu, A Domingo-Albòs
JournalHaematologica (Haematologica) 1993 Mar-Apr Vol. 78 Issue 2 Pg. 132-4 ISSN: 0390-6078 [Print] Italy
PMID8349191 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Biomarkers, Tumor
  • Amsacrine
  • Cytarabine
  • Etoposide
  • Cyclophosphamide
  • Prednisolone
  • Mitoxantrone
  • Vindesine
  • Daunorubicin
Topics
  • Acute Disease
  • Amsacrine (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Biomarkers, Tumor
  • Bone Marrow (pathology)
  • Catheterization, Central Venous (adverse effects)
  • Cyclophosphamide (administration & dosage)
  • Cytarabine (administration & dosage)
  • Daunorubicin (administration & dosage)
  • Etoposide (administration & dosage)
  • Female
  • Humans
  • Leukemia, Myeloid (drug therapy, pathology)
  • Leukemic Infiltration
  • Middle Aged
  • Mitoxantrone (administration & dosage)
  • Neoplasm Seeding
  • Prednisolone (administration & dosage)
  • Remission Induction
  • Salvage Therapy
  • Skin (pathology)
  • Vindesine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: